Correction to: BMC Immunol (2021) 22:3
https://doi.org/10.1186/s12865-020-00396-3
It was highlighted that the original article [1] contained errors in the authors affiliations. This Correction article shows the incorrect and correct author affiliations. The original article has been updated.
Incorrect
Weigang Xiu1 and Jingjing Luo2,3
1 Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, PR China. 2 Department of Laboratory Medicine, West China Second University Hospital, Sichuan University, Chengdu 610041, PR China. 3 Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu 610041, PR China.
Correct
Weigang Xiu1,2,3 and Jingjing Luo1,2
1 Department of Laboratory Medicine, West China Second University Hospital, Sichuan University. 2 Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education. 3 Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, PR China.
Reference
- 1.Xiu W, Luo J. CXCL9 secreted by tumor-associated dendritic cells up-regulates PD-L1 expression in bladder cancer cells by activating the CXCR3 signaling. BMC Immunol. 2021;22:3. doi: 10.1186/s12865-020-00396-3. [DOI] [PMC free article] [PubMed] [Google Scholar]